Serhii Zabolotnii · arXiv (Cornell University) 2026 · 2026
DOI: 10.48550/arxiv.2609.39717
Counts differ because each database indexes a different set of publications. We treat OpenAlex as the canonical count; Google Scholar is not shown (no API, and crawling it violates its ToS).
Benchmarks, audits, and agent protocols describe performance, permissions, and repair, but not how observed evidence should change an agent's authority during a consequential task. We call this the assurance-transition gap. We propose a Runtime Assurance Contract (RAC), a policy-level formal schema binding autonomy boundaries, component eligibility, evidence state, transition policy, human-review capacity, and non-compensatory gates. Under RAC, soft metrics may inform routing, whereas a failed or unknown mandatory gate forces retry, switch, escalation, deferral, or stop; aggregate performance cannot authorize action. We define the contract, an evidence record, a permission rule, and five invariants, and illustrate them in clinical, industrial, and judicial failure probes. We then report a deterministic failure-injection study in agentic coding: 280 constructed cases evaluated by a gate conjunction, a score-only rule, and a restricted protocol baseline. At the published example weights and threshold, the score rule admits 80 of 100 block-required injections and all 40 review-required injections. Tuned in hindsight, it matches the conjunction on this corpus. For positive weights, a positive threshold, binary risk signals, zero-signal controls, and an injected case firing each signal alone, we show that exact agreement holds if and only if the threshold does not exceed the smallest weight. A separate set of 18 hand-authored traces checks version-pinned evidence and review transitions against simpler policy variants. In a further prospective synthetic holdout of 24 episodes, two blinded LLM judges assign identical labels to all 72 action attempts; RAC and a separately implemented full stateful baseline both match these labels. These studies test mechanisms on synthetic cases; they establish neither deployed safety nor cross-domain effectiveness.
No comments yet — start the discussion below.